Consoldiated Statements of Cash Flows - USD ($)	6 Months Ended
	May. 31, 2015	May. 31, 2014
Operating activities:
Net loss	$ (436,391)	$ (372,151)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation	$ 4,000	13,297
Provision for bad debt		(731)
Amortization of debt discount	$ 305,153	$ 529,375
Amortization of financing costs	5,305
Gain on troubled debt restructuring	$ (2,065,614)
Gain on sale of subsidiary		$ (640,180)
Gain on settlement of derivative liabilities	$ (1,223,448)	(300,686)
Change in fair value of derivative liabilities	$ 3,017,461	(14,072)
Changes in operating assets and liabilities:
Accounts receivable		(5,544)
Prepaid expenses and other current assets	$ 3,337	5,228
Other assets	(31,337)	44,733
Accounts payable and accrued liabilities	140,417	475,689
Accounts payable and accrued liabilities- related party	148,457	49,653
Due to Pension Benefit Guaranty Corporation	50,434	48,094
Net cash used in operating activities	(82,226)	$ (167,301)
Cash flows from investing activities:
Cash acquired in Canalytix acquisition	303
Net cash provided by investing activities	303
Cash flows from financing activities:
Proceeds from borrowings	130,500	$ 276,500
Principal payments of debt	(44,100)	(101,216)
Net cash provided by financing activities	86,400	175,284
Increase in cash and cash equivalents	4,477	7,983
Cash and cash equivalents at beginning of period	1,832	17,242
Cash and cash equivalents at the end of period	$ 6,309	$ 25,225
Supplemental disclosure of cash flow information:
Cash paid during the period for: Income taxes
Cash paid during the period for: Interest		$ 52,899
Non-cash financing transactions:
Fair value of derivative liabilities to discount on debt	$ 193,780	$ 230,837
Settlement of accrued interest with issuance of preferred stock	100,000
Settlement of payables with issuance of warrants	20,000
Conversion of accrued liabilities to notes payable	$ 150,731	$ 73,934